🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 82835W108
- Market Cap
- Mid Cap · $569 Million
- IPO
- 12/4/2020 · $21.00/share
- Previous Symbol
- SBTX (changed 11/8/2022)
- Previous Name
- Silverback Therapeutics, Inc.
Business: Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
Company Contact
- CEO
- Richard Lowenthal
- CFO
- Kathleen Scott
- Headquarters
- 500 Fairview Ave N, Suite 600, Seattle, WA 98109
- Phone
- 206-456-2900
- Investor Relations
- Justin Chakma · 858-771-9307 · justinc@ars-pharma.com